StreetInsider.com News Articles

Form 424B5 Tenon Medical, Inc.

Fri, 16 Oct 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20261016/27198195.html

Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026

Thu, 15 Oct 2026 08:30:00 -0400

LOS GATOS, CA / ACCESS Newswire / October 15, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients suffering from certain sacro-pelvic disorders, today announced that the U.S. Patent and Trademark Office (USPTO) has issued 8 new patents to the Company so far in 2026 fiscal year. With these additions, Tenon holds 38 issued U.S. patents and 9 international patents and has 31 U.S. and foreign patent applications pending.

The Company believes that these 8 recently issued patents continue to solidify and

Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026

Thu, 15 Oct 2026 08:30:00 -0400

The Company believes that these 8 recently issued patents continue to solidify and

Form EFFECT Tenon Medical, Inc.

Tue, 13 Oct 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20261013/27176276.html

Form 424B3 Tenon Medical, Inc.

Fri, 09 Oct 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20261009/27171775.html

Form 3 Tenon Medical, Inc. For: Oct 01 Filed by: Batton Thomas Henry Jr

Fri, 09 Oct 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20261009/27171471.html

Form S-3 Tenon Medical, Inc.

Mon, 05 Oct 2026 06:01:00 -0400

si-local-file:///var/storage/secattach/20261005/27145051.html

Tenon Medical launches SImmetry+ SI joint fusion screw commercially

Wed, 30 Sep 2026 08:31:15 -0400

Tenon Medical, Inc. (NASDAQ: TNON) has announced the full commercial launch of its titanium 3D-printed lateral screw as part of the SImmetry+ SI Joint Fusion System, following the completion of a limited Alpha launch.

According to a company statement, the Alpha launch — which involved existing SImmetry users and new physicians — generated approximately $1.2 million in preliminary, unaudited incremental revenue from late Q4 2025 through Q3 2026.

Tenon said it plans to expand its instrument set inventory to support anticipated demand. The company also added two implant sizes to the SImmetry+ portfolio in response to feedback from Alpha users and newly

Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch

Wed, 30 Sep 2026 08:30:00 -0400

LOS GATOS, CA / ACCESS Newswire / September 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced the full commercial launch of its new titanium 3D- printed lateral screw as part of the SImmetry+ SI Joint Fusion System following the successful completion of the implant's Alpha launch. The limited Alpha launch, involving existing SImmetry users and new physicians, generated approximately $1.2 million⁽¹⁾ in incremental revenue for a period beginning in late Q4 2025 through Q3 2026. The Company

Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch

Wed, 30 Sep 2026 08:30:00 -0400

Form D Tenon Medical, Inc.

Mon, 21 Sep 2026 06:00:00 -0400

si-local-file:///var/storage/secattach/20260921/27082441.html

Form 8-K Tenon Medical, Inc. For: Sep 11

Wed, 16 Sep 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260916/27071212.html

WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338

Mon, 14 Sep 2026 13:00:00 -0400

JERSEY CITY, N.J., Sept. 14, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ: TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders has closed its previously announced warrant inducement agreement with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's

WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338

Mon, 14 Sep 2026 13:00:00 -0400

Tenon Medical closes warrant deal, raises $2.87M

Mon, 14 Sep 2026 12:42:25 -0400

Tenon Medical, Inc. (NASDAQ: TNON) has closed a warrant inducement agreement with an institutional investor, generating gross proceeds of $2,872,338, according to a press release from the Los Gatos, California-based medical device company.

Under the terms of the transaction, the investor exercised outstanding warrants to purchase 572,179 shares of common stock. In exchange, the investor received new unregistered warrants to purchase up to 858,269 shares of common stock, equal to 150% of the shares issued through the exercised warrants. The new warrants carry an exercise price of $5.02 per share, are immediately exercisable, and expire five years from the date of

Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338

Mon, 14 Sep 2026 12:35:00 -0400

LOS GATOS, CA / ACCESS Newswire / September 14, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced today it has closed its previously announced warrant inducement agreement with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants").

In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exercising holder received new unregistered warrants

Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338

Mon, 14 Sep 2026 12:35:00 -0400

In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exercising holder received new unregistered warrants

Form 4 Tenon Medical, Inc. For: Aug 26 Filed by: HRT FINANCIAL LP

Fri, 11 Sep 2026 14:14:00 -0400

si-local-file:///var/storage/secattach/20260911/27052388.html

Tenon Medical raises $2.87M through warrant inducement deal

Fri, 11 Sep 2026 14:00:45 -0400

Tenon Medical, Inc. (NASDAQ: TNON) has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants for 572,179 shares of common stock, generating gross proceeds of approximately $2,872,338, according to a press release from WallachBeth Capital LLC.

In exchange for the immediate exercise of the existing warrants, the investor will receive new unregistered warrants in a private placement to purchase up to 858,269 shares of common stock, equal to 150% of the shares issued through the warrant exercise. The new warrants carry an exercise price of $5.02 per share, are immediately exercisable upon issuance, and expire five years

WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338

Fri, 11 Sep 2026 14:00:00 -0400

JERSEY CITY, N.J., Sept. 11, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants").

WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338

Fri, 11 Sep 2026 14:00:00 -0400

Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338

Fri, 11 Sep 2026 13:22:00 -0400

LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders announced today it has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants"). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exercising holders will receive in a private

Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338

Fri, 11 Sep 2026 13:22:00 -0400

Form 4 Tenon Medical, Inc. For: Sep 08 Filed by: Williamson Kevin

Thu, 10 Sep 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260910/27048268.html

Big Pharma Setbacks Create a New Wave of Rebound Plays

Thu, 10 Sep 2026 14:12:41 -0400

DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The biotech tape delivered a brutal reminder of one of the sector’s oldest rules: even a fundamentally strong company can get caught in the crossfire when a major drugmaker suffers a pipeline setback. Yesterday, a setback at Novartis (NYSE: NVS) sent ripples across the biotech space, pressuring companies whose own clinical and corporate announcements remained decidedly positive.

The resulting selloff highlighted just how quickly investors can shift from company-specific fundamentals to broader sector risk. For smaller biotech names, that indiscriminate pressure can be painful, but it can also create potentially compelling